Startup entity

Neuritek Therapeutics, Inc.

Company

Every one of those 1 sits in a single category, acquisition. Neuritek Therapeutics, Inc. is most often covered alongside Wellgistics Health Inc., which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 2.7 for the broader beat in this window.

Last mentioned: Mar 23, 2026

Entity pulse

Recent coverage · Neuritek Therapeutics, Inc.

1 story
7 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Neuritek Therapeutics, Inc.

Every one of those 1 sits in a single category, acquisition. Neuritek Therapeutics, Inc. is most often covered alongside Wellgistics Health Inc., which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 2.7 for the broader beat in this window. At 7, the average consequence score sits above the same-window beat average of 6.6. We currently track 1 Startup story that mention Neuritek Therapeutics, Inc., all published on March 23, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 38 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Neuritek Therapeutics, Inc.. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning Neuritek Therapeutics, Inc. 1

Acquisitions Positive

Wellgistics Health Signs $105M LOI to Acquire Neuritek Therapeutics

Wellgistics Health Inc. has signed a $105 million Letter of Intent to acquire Neuritek Therapeutics, a biotech firm specializing in neurological and psychiatric disorder treatments. The deal marks a significant strategic pivot for Wellgistics into the high-stakes central nervous system (CNS) therapeutic market.

2 sources

Neuritek Therapeutics, Inc. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.